Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 16, 2025 06:52 ET | Source: Research and Markets

Nuclear Medicine Equipment Market Analysis Report 2025-2035

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Equipment Market - A Global and Regional Analysis: Focus on Application, End User, Country, and Region - Analysis and Forecast,...
October 16, 2025 02:00 ET | Source: AdvanCell

AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors

Kay was instrumental in driving the successful development and commercialization of Xofigo®, the first and only approved alpha therapy to date SYDNEY, Australia - October 16, 2025 – AdvanCell, a...
October 12, 2025 18:05 ET | Source: AdvanCell

AdvanCell to present promising clinical trial results of ADVC001, a novel Lead-212-based PSMA-targeted alpha therapy for prostate cancer, at ESMO 2025

AdvanCell to present promising clinical trial results of ADVC001, a novel Lead-212-based PSMA-targeted alpha therapy for prostate cancer, at ESMO 2025 Results from the Phase 1b dose escalation of the...
October 08, 2025 06:22 ET | Source: Curium

Oxford Set To Benefit From New Technology to Diagnose Disease

Curium will shortly open a new facility to manufacture cutting-edge diagnosis technology for diseases like cancer at the Churchill Hospital site, part of Oxford University Hospitals NHS Foundation...
September 29, 2025 07:00 ET | Source: AdvanCell

AdvanCell to Highlight the Potential of Pb-212-based Targeted Alpha Therapies for Cancer at EANM’25

Sydney, Australia – September 29, 2025 – AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, today announced that it will present six...
July 31, 2025 06:15 ET | Source: ICPO Foundation

ICPO und SBMN vertiefen ihre Zusammenarbeit zur Förderung von Klinischen Theranostik-Zentren der Exzellenz in Brasilien

Die ICPO-Akkreditierung erfolgt gemäß internationalen Theranostik-Richtlinien, während die ICPO Academy for Theranostics die Partnerschaft von Anfang an stärkt. 31. Juli 2025 – Wiesbaden,...
July 31, 2025 06:15 ET | Source: ICPO Foundation

ICPO and SBMN deepen their collaboration to advance Clinical Theranostics Centers of Excellence in Brazil

ICPO accreditation following international theranostics guidelines and ICPO Academy for Theranostics will fuel the partnership right from start. July 31, 2025 – Wiesbaden, Germany, and Sao Paulo,...
July 03, 2025 04:12 ET | Source: Research and Markets

Business and Investment Opportunities in Nuclear Medicine 2025-2030: North America Leads, Asia-Pacific Races

Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Market Size, Share & Trends Analysis Report by Product (Diagnostics, Therapeutics), Application (Cardiology, Neurology, Oncology),...
June 21, 2025 06:20 ET | Source: ICPO Foundation

ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen

Weitere Gründungsmitglieder sind die European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis und RayzeBio, ein Unternehmen von Bristol Myers Squibb. Wiesbaden, 21. Juni 2025 – Die...
June 21, 2025 06:20 ET | Source: ICPO Foundation

ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients

Further founding members include the European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis, and RayzeBio, a Bristol Myers Squibb company. Wiesbaden, June 21, 2025 – The...